MedPath

The Impact of RPh201 on Chronic Vegetative State (CVS): fMRI Study

Phase 1
Suspended
Conditions
Chronic Vegetative State
Interventions
Drug: Saline
Registration Number
NCT01438684
Lead Sponsor
Hadassah Medical Organization
Brief Summary

The aim is to evaluate the impact of RPh201 on brain activity in chronic vegetative state patients. The assessment will be done using clinical measurements and functional MRI studies.

Detailed Description

Not available

Recruitment & Eligibility

Status
SUSPENDED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • chronic vegetative state patients
Exclusion Criteria
  • allergic reaction to treatment
  • patients that can not undergo MRI
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RPh201 groupRPh2017 patients will receive the treatment
non RPh201 groupSaline3 patients will receive placebo
Primary Outcome Measures
NameTimeMethod
consciousness level measured clinically6 months

Each patient will undergo a behavioral assessment (using the Coma Recovery Scale Revised) before treatment and every 2 weeks during the treatment period as well as 3 months following the end of the treatment. Complete blood counts, electrolytes, liver function tests, renal function tests and ECG will be performed every two weeks.

Secondary Outcome Measures
NameTimeMethod
Functional magnetic resonance imaging of cortical activity6 months

3 scans will be performed: before treatment, after three months of treatment and 3 months after cessation of treatment. Scanning sessions will include a hierarchical auditory paradigm, an imagery task and resting state fMRI

Trial Locations

Locations (1)

Netta Levin

🇮🇱

Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath